Opioids, Extracellular Vesicles and BBB Innate Immunity
阿片类药物、细胞外囊泡和 BBB 先天免疫
基本信息
- 批准号:9381158
- 负责人:
- 金额:$ 23.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-06-01 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:3&apos Untranslated RegionsAddressAdhesionsAlgorithmsAntiviral AgentsBiomedical EngineeringBlood - brain barrier anatomyCCL2 geneCCR5 geneCellsDataEngineeringEnzyme-Linked Immunosorbent AssayHIVHIV InfectionsHeroinHeroin UsersImmune signalingImmunityImmunologic SurveillanceImpairmentIn VitroInfectionInflammationInflammatory ResponseInjecting drug userIntercellular adhesion molecule 1MediatingMicroRNAsMorphineNatural ImmunityNeuraxisNeuronal InjuryNeuronsOpiatesOpioidPlasmaPlayPredispositionProteinsRNAResearchRoleSmall RNASourceSystemTight JunctionsUnited StatesValidationVascular Cell Adhesion Molecule-1ViralViral Physiologyantiviral immunitybrain cellbrain endothelial cellcofactorexosomeextracellular vesiclesimmune activationimmunoregulationin vivoinjection drug useintercellular communicationmacrophagemicroRNA biomarkersmigrationmonocyteneuronal survivalneurotoxicneurotoxicitynovelopioid usesensortranscriptome sequencingtransmission process
项目摘要
Abstract
Extracellular vesicles (EVs) play an important role in neuronal survival and immune surveillance of the central
nervous system (CNS) by mediating the intercellular communication between neurons and other brain cells. Our early
in vitro and in vivo studies showed that opioids (morphine and heroin) and/or HIV could inhibit the expression of a
number of the intracellular and circulating HIV restriction microRNAs (miRNAs). Recently, we demonstrated that
EVs could shuttle antiviral signals from immune-activated brain microvascular endothelial cells (BMVEC) to
macrophages, resulting in HIV inhibition. In addition, we showed that plasma EVs from HIV-infected subjects
enriched several miRNAs that have neurotoxic effect (miR-21 and let-7) or target tight junction proteins (miR-17 and
miR-20a). We thus hypothesize that opioids and/or HIV impair the blood-brain barrier (BBB) integrity and exert
neurotoxicity via EVs-mediated intercellular transmission of miRNAs. We propose two specific aims to address
this hypothesis: Specific Aim 1. To determine the impact of EVs-mediated miRNAs on BBB innate immunity against
HIV and neuronal injury in the context of opioid use; Specific Aim 2. To mechanistically study the role of BMVEC-
and plasma-derived EVs in the BBB innate antiviral immunity and neuronal injury, we will generate bioengineered
exosomes that contain the specific miRNAs. We will then determine the 3’ UTR targets of these miRNAs and whether
these miRNAs are involved in the modulation of immune activation and inflammation in BMVEC and neuronal cells.
The findings from this project will provide scientific evidence of EVs-mediated BBB innate immunity against HIV and
a novel mechanism for opioid and/or HIV-mediated neuronal injury.
抽象的
细胞外蔬菜(EV)在中央的神经元存活和免疫监测中起重要作用
神经系统(CNS)通过介导神经元与其他脑细胞之间的细胞间通信。我们的早期
体外和体内研究表明,阿片类药物(吗啡和海洛因)和/或HIV可以抑制A的表达
细胞内和循环的HIV限制microRNA(miRNA)的数量。最近,我们证明了
电动汽车可以从免疫激活的脑微血管内皮细胞(BMVEC)从免疫激活的抗病毒信号穿上抗病毒信号至
巨噬细胞,导致HIV抑制。此外,我们证明了来自HIV感染受试者的血浆EV
富集具有神经毒性作用(miR-21和Let-7)或靶向紧密连接蛋白(miR-17和MiR-17和
mir-20a)。因此,我们假设阿片类药物和/或HIV损害了血脑屏障(BBB)的完整性和运动
通过电动汽车介导的miRNA的细胞间传播神经毒性。我们提出了两个特定的目的来解决
该假设:具体目的1。确定电动汽车介导的miRNA对BBB先天免疫的影响
在使用阿片类药物的情况下,艾滋病毒和神经元损伤;具体目标2。机械地研究BMVEC-的作用
BBB先天抗病毒免疫学和神经元损伤中的血浆衍生的电动汽车,我们将产生生物工程
包含特定miRNA的外泌体。然后,我们将确定这些miRNA的3’UTR目标以及是否
这些miRNA参与了BMVEC和神经元细胞中免疫激活和炎症的调节。
该项目的发现将提供电动汽车介导的BBB先天免疫对艾滋病毒和艾滋病毒的科学证据
阿片类药物和/或HIV介导的神经元损伤的新型机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WENZHE HO其他文献
WENZHE HO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WENZHE HO', 18)}}的其他基金
Target Host Epigenetic Regulation of HIV Proviruses to Reinforce Viral Deep Latency in Microglia
HIV原病毒的靶宿主表观遗传调控可增强小胶质细胞中病毒的深潜伏期
- 批准号:
10748760 - 财政年份:2023
- 资助金额:
$ 23.78万 - 项目类别:
Effect of Methamphetamine and/or HIV on Human iPSCs-derived microglia and Neuron
甲基苯丙胺和/或 HIV 对人 iPSC 衍生的小胶质细胞和神经元的影响
- 批准号:
10210377 - 财政年份:2020
- 资助金额:
$ 23.78万 - 项目类别:
HIV, Methamphetamine and Human iPSC-derived Microglia-containing Cerebral Organoids
HIV、甲基苯丙胺和人类 iPSC 衍生的含有小胶质细胞的大脑类器官
- 批准号:
10611364 - 财政年份:2020
- 资助金额:
$ 23.78万 - 项目类别:
Effect of Methamphetamine and/or HIV on Human iPSCs-derived microglia and Neuron
甲基苯丙胺和/或 HIV 对人 iPSC 衍生的小胶质细胞和神经元的影响
- 批准号:
10031319 - 财政年份:2020
- 资助金额:
$ 23.78万 - 项目类别:
HIV, Methamphetamine and Human iPSC-derived Microglia-containing Cerebral Organoids
HIV、甲基苯丙胺和人 iPSC 衍生的含有小胶质细胞的大脑类器官
- 批准号:
10205018 - 财政年份:2020
- 资助金额:
$ 23.78万 - 项目类别:
HIV, Methamphetamine and Human iPSC-derived Microglia-containing Cerebral Organoids
HIV、甲基苯丙胺和人 iPSC 衍生的含有小胶质细胞的大脑类器官
- 批准号:
10398189 - 财政年份:2020
- 资助金额:
$ 23.78万 - 项目类别:
HIV, Methamphetamine and Human iPSC-derived Microglia-containing Cerebral Organoids
HIV、甲基苯丙胺和人类 iPSC 衍生的含有小胶质细胞的大脑类器官
- 批准号:
10055449 - 财政年份:2020
- 资助金额:
$ 23.78万 - 项目类别:
Role of miRNAs in Methamphetamine/HIV-mediated Immune Activation
miRNA 在甲基苯丙胺/HIV 介导的免疫激活中的作用
- 批准号:
10357940 - 财政年份:2018
- 资助金额:
$ 23.78万 - 项目类别:
Opioids, Extracellular Vesicles and BBB Innate Immunity
阿片类药物、细胞外囊泡和 BBB 先天免疫
- 批准号:
9485926 - 财政年份:2017
- 资助金额:
$ 23.78万 - 项目类别:
相似海外基金
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
- 批准号:
10817516 - 财政年份:2023
- 资助金额:
$ 23.78万 - 项目类别:
Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2
宿主与 SARS-CoV-2 之间的战斗中病毒基因调控的新机制
- 批准号:
10725416 - 财政年份:2023
- 资助金额:
$ 23.78万 - 项目类别:
Genetic and pharmacologic elimination of myotonia from myotonic dystrophy type 1
通过遗传和药物消除 1 型强直性肌营养不良引起的肌强直
- 批准号:
10750357 - 财政年份:2023
- 资助金额:
$ 23.78万 - 项目类别:
Development of Utrophin Site Blocking Oligos (SBOs) to Treat Duchenne Muscular Dystrophy (DMD)
开发 Utropin 位点封闭寡核苷酸 (SBO) 来治疗杜氏肌营养不良症 (DMD)
- 批准号:
10678195 - 财政年份:2023
- 资助金额:
$ 23.78万 - 项目类别: